<DOC>
	<DOCNO>NCT00376532</DOCNO>
	<brief_summary>Assess whether serum level MMP 2 MMP 9 correlate episode ventricular tachycardia fibrillation patient implantable cardioverter defibrillator device .</brief_summary>
	<brief_title>Extracellular Matrix Marker Arrhythmia Risk ( EMMA )</brief_title>
	<detailed_description>Sudden cardiac death ( SCD ) responsible 300,000-450,000 death per year United States . While well know patient ischemic non-ischemic cardiomyopathy ( ICM , NICM ) increase risk SCD , little beyond ejection fraction proven useful noninvasive predictor risk stratify patient . Myocardial scar validate arrhythmic substrate ischemic population ; majority successful ablation lethal ventricular arrhythmia perform tissue peri-infarct region . Scar provide anatomic electrical boundary peri-infarct zone may lead area slow conduction due disruption inter-myocyte electrical conduction . Myocardial scar less organize collagen deposition disrupt typical cardiac extracellular matrix . The collagen matrix provide mechanical support myocardium dictate ventricular shape , size stiffness . While typically relatively dormant , fibrillar collagen matrix reflect dynamic relationship collagen synthesis mediate fibroblast collagen degradation perform matrix metalloproteinases ( MMP ) . A marker scar burden marker could assess patient 's predilection form scar either ischemic non-ischemic insult may useful risk stratify population . Since MMP level may fluctuate course ischemic nonischemic injury static promoter sequence confers higher level MMP expression ischemic nonischemic insult may prove reliable marker . Functional polymorphisms MMP-9 gene promoter show multivariate analysis independent predictor cardiac mortality regardless mechanism heart failure .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Death , Sudden</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>LVEF â‰¤ 35 % measure within 6 month ICD implantation NYHA class IIIV time ICD implantation ICD implantation least 1 year prior enrollment Status post heart transplant Known malignancy past 2 year . Recent procedure , intervention surgery within past 90 day Acute MI , CABG , PTCA/stent within past 2 month . Active rheumatoid arthritis pulmonary hepatic fibrosis . Taking chronic steroid therapy medical condition Currently pregnant Enrolled concurrent study may confound result study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Cardiac Ischemia</keyword>
	<keyword>Cardiac Arrhythmia</keyword>
	<keyword>Defibrillator</keyword>
	<keyword>Matrix Metalloproteinase</keyword>
	<keyword>Genetic Polymorphism</keyword>
</DOC>